INDRAYANI BIOTECH
|
INDRAYANI BIOTECH Last 5 Year Cashflow Statement History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Profit Before Tax | ₹10 Cr | ₹12 Cr | ₹4.44 Cr | ₹-11 Cr | ₹0.81 Cr |
Adjustment | ₹14 Cr | ₹9.37 Cr | ₹2.52 Cr | ₹4.52 Cr | ₹2.12 Cr |
Changes In working Capital | ₹-54 Cr | ₹-5.11 Cr | ₹-2.85 Cr | ₹6.95 Cr | ₹3.03 Cr |
Cash Flow after changes in Working Capital | ₹-30 Cr | ₹16 Cr | ₹4.11 Cr | ₹0.26 Cr | ₹5.96 Cr |
Cash Flow from Operating Activities | ₹-30 Cr | ₹16 Cr | ₹4.11 Cr | ₹0.26 Cr | ₹5.96 Cr |
Cash Flow from Investing Activities | ₹-16 Cr | ₹-47 Cr | ₹-0.56 Cr | ₹-0.70 Cr | ₹-3.67 Cr |
Cash Flow from Financing Activities | ₹44 Cr | ₹33 Cr | ₹-2.73 Cr | ₹-0.28 Cr | ₹-1.28 Cr |
Net Cash Inflow / Outflow | ₹-2.45 Cr | ₹1.53 Cr | ₹0.82 Cr | ₹-0.72 Cr | ₹1.01 Cr |
Opening Cash & Cash Equivalents | ₹3.04 Cr | ₹1.50 Cr | ₹0.68 Cr | ₹1.40 Cr | ₹0.39 Cr |
Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - | - | - | - |
Cash & Cash Equivalent of Subsidiaries under liquidations | - | - | - | - | - |
Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - | - | - |
Effect of Foreign Exchange Fluctuations | - | - | - | - | - |
Closing Cash & Cash Equivalent | ₹0.58 Cr | ₹3.04 Cr | ₹1.50 Cr | ₹0.68 Cr | ₹1.40 Cr |
Compare Cashflow Statement of peers of INDRAYANI BIOTECH
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
INDRAYANI BIOTECH | ₹164.9 Cr | 0.9% | -2.2% | -42.3% | Stock Analytics | |
No other companies found in this Industry |
INDRAYANI BIOTECH Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
INDRAYANI BIOTECH | 0.9% |
-2.2% |
-42.3% |
SENSEX | 1.9% |
-0.4% |
10.4% |
You may also like the below Video Courses